N. Solomonidi

Heparin Binding Protein for the Early Diagnosis and Prognosis of Sepsis in the Emergency Department: The Prompt Multicenter Study

E. Giamarellos‐Bourboulis, T. Gkavogianni, P. Koutoukas, 2021, Shock.

A 29-MRNA HOST RESPONSE WHOLE-BLOOD SIGNATURE IMPROVES PREDICTION OF 28-DAY MORTALITY AND 7-DAY INTENSIVE CARE UNIT CARE IN ADULTS PRESENTING TO THE EMERGENCY DEPARTMENT WITH SUSPECTED ACUTE INFECTION AND/OR SEPSIS

T. Sweeney, F. Uhle, E. Giamarellos‐Bourboulis, 2022, Shock.

Soluble Urokinase Receptor (SuPAR) in COVID-19-Related AKI.

S. Loosen, F. Tacke, R. Pop-Busui, 2020, Journal of the American Society of Nephrology : JASN.

SUSCEPTIBILITY PROFILES AND CLINICAL EFFICACY OF ANTIFUNGALS AGAINST CANDIDA BLOODSTREAM ISOLATES FROM CRITICALLY ILL PATIENTS: FOCUS ON INTRAVENOUS ITRACONAZOLE.

G. Dimopoulos, G. Samonis, E. Giamarellos‐Bourboulis, 2019, International journal of antimicrobial agents.

A 29-mRNA host response test from blood accurately distinguishes bacterial and viral infections among emergency department patients

T. Sweeney, E. Giamarellos‐Bourboulis, O. Liesenfeld, 2020, Intensive Care Medicine Experimental.

A randomized clinical trial of bermekimab treatment for clinical improvement of systemic sclerosis

S. Ktena, A. Elezoglou, E. Giamarellos‐Bourboulis, 2023, iScience.